Citation 90425

WANG,H: TIAN,X: PAN,YJ:. (2003). ANTITUMOR SESQUITERPENES FROM EUONYMUS NANOIDES.. 86(10)

Citation Details

Title	ANTITUMOR SESQUITERPENES FROM EUONYMUS NANOIDES.
Authors	WANG,H: TIAN,X: PAN,YJ:
Year	2003
Volume	86
Issue	10

Summary

Year: 2003

Journal: Unknown

Organisms and Their Experiments (1)

Euonymus nanoides (CELASTRACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	VOUCHER SPECIMEN REPORTED FORUV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	AGAROFURAN,BETA-DIHYDRO: 6-ALPHA-13-BIS-(ACETYL-OXY)-9-BETA-(CINNAMOYL-OXY)-1-BETA-[FURAN-3-YL-CARBONYL)-OXY]-4-ALPHA-HYDROXY:	None
2	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	AGAROFURAN,BETA-DIHYDRO: 6-ALPHA-13-BIS-(ACETYL-OXY)-9-BETA-(CINNAMOYL-OXY)-1-BETA-[FURAN-3-YL-CARBONYL)-OXY]-4-ALPHA-HYDROXY:	WEAK ACTIVITY
3	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	AGAROFURAN,BETA-DIHYDRO: 6-ALPHA-13-BIS-(ACETYL-OXY)-9-BETA-(CINNAMOYL-OXY)-1-BETA-[FURAN-3-YL-CARBONYL)-OXY]-4-ALPHA-HYDROXY:	WEAK ACTIVITY
4	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	AGAROFURAN,BETA-DIHYDRO: 6-ALPHA-13-BIS-(ACETYL-OXY)-9-BETA-(CINNAMOYL-OXY)-1-BETA-[FURAN-3-YL-CARBONYL)-OXY]-4-ALPHA-HYDROXY:	WEAK ACTIVITY
5	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	AGAROFURAN,BETA-DIHYDRO: 6-ALPHA-13-BIS-(ACETYL-OXY)-9-BETA-(CINNAMOYL-OXY)-1-BETA-[FURAN-3-YL-CARBONYL)-OXY]-4-ALPHA-HYDROXY:	WEAK ACTIVITY
6	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	AGAROFURAN,BETA-DIHYDRO: 12-(ACETYL-OXY)-9-BETA-(BENZOYL-OXY)-4-ALPHA-HYDROXY-1-BETA-6-ALPHA-BIS-(2-METHYL-BUTANOYL)-OXY]:	None
7	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	AGAROFURAN,BETA-DIHYDRO: 12-(ACETYL-OXY)-9-BETA-(BENZOYL-OXY)-4-ALPHA-HYDROXY-1-BETA-6-ALPHA-BIS-(2-METHYL-BUTANOYL)-OXY]:	WEAK ACTIVITY
8	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	AGAROFURAN,BETA-DIHYDRO: 12-(ACETYL-OXY)-9-BETA-(BENZOYL-OXY)-4-ALPHA-HYDROXY-1-BETA-6-ALPHA-BIS-(2-METHYL-BUTANOYL)-OXY]:	WEAK ACTIVITY
9	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	AGAROFURAN,BETA-DIHYDRO: 12-(ACETYL-OXY)-9-BETA-(BENZOYL-OXY)-4-ALPHA-HYDROXY-1-BETA-6-ALPHA-BIS-(2-METHYL-BUTANOYL)-OXY]:	INACTIVE
10	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	AGAROFURAN,BETA-DIHYDRO: 12-(ACETYL-OXY)-9-BETA-(BENZOYL-OXY)-4-ALPHA-HYDROXY-1-BETA-6-ALPHA-BIS-(2-METHYL-BUTANOYL)-OXY]:	ACTIVE
11	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	AGAROFURAN,BETA-DIHYDRO: 1-BETA-6-ALPHA-13-TRIS-(ACETYL-OXY)-9-BETA-(CINNAMOYL-OXY)-4-ALPHA-HYDROXY:	None
12	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF EXTRACT - IN VITRO	AGAROFURAN,BETA-DIHYDRO: 1-BETA-6-ALPHA-13-TRIS-(ACETYL-OXY)-9-BETA-(CINNAMOYL-OXY)-4-ALPHA-HYDROXY:	INACTIVE
13	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	AGAROFURAN,BETA-DIHYDRO: 1-BETA-6-ALPHA-13-TRIS-(ACETYL-OXY)-9-BETA-(CINNAMOYL-OXY)-4-ALPHA-HYDROXY:	WEAK ACTIVITY
14	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	AGAROFURAN,BETA-DIHYDRO: 1-BETA-6-ALPHA-13-TRIS-(ACETYL-OXY)-9-BETA-(CINNAMOYL-OXY)-4-ALPHA-HYDROXY:	INACTIVE
15	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	AGAROFURAN,BETA-DIHYDRO: 6-ALPHA-13-BIS-(ACETYL-OXY)-9-BETA-(BENZOYL-OXY)-4-ALPHA-HYDROXY-1-BETA-[(2-METHYL-BUTANOYL)-OXY]:	None
16	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	AGAROFURAN,BETA-DIHYDRO: 6-ALPHA-13-BIS-(ACETYL-OXY)-9-BETA-(BENZOYL-OXY)-4-ALPHA-HYDROXY-1-BETA-[(2-METHYL-BUTANOYL)-OXY]:	WEAK ACTIVITY
17	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	AGAROFURAN,BETA-DIHYDRO: 6-ALPHA-13-BIS-(ACETYL-OXY)-9-BETA-(BENZOYL-OXY)-4-ALPHA-HYDROXY-1-BETA-[(2-METHYL-BUTANOYL)-OXY]:	WEAK ACTIVITY
18	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	AGAROFURAN,BETA-DIHYDRO: 6-ALPHA-13-BIS-(ACETYL-OXY)-9-BETA-(BENZOYL-OXY)-4-ALPHA-HYDROXY-1-BETA-[(2-METHYL-BUTANOYL)-OXY]:	INACTIVE
19	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	AGAROFURAN,BETA-DIHYDRO: 6-ALPHA-13-BIS-(ACETYL-OXY)-9-BETA-(BENZOYL-OXY)-4-ALPHA-HYDROXY-1-BETA-[(2-METHYL-BUTANOYL)-OXY]:	WEAK ACTIVITY
20	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	AGAROFURAN,BETA-DIHYDRO: 1-BETA-2-BETA-6-ALPHA-TRIS-(ACETYL-OXY)-9-ALPHA-(BENZOYL-OXY)-4-ALPHA-HYDROXY-13-[(2-METHYL-BUTANOYL)-OXY]:	None
21	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	AGAROFURAN,BETA-DIHYDRO: 1-BETA-2-BETA-6-ALPHA-TRIS-(ACETYL-OXY)-9-ALPHA-(BENZOYL-OXY)-4-ALPHA-HYDROXY-13-[(2-METHYL-BUTANOYL)-OXY]:	INACTIVE
22	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	AGAROFURAN,BETA-DIHYDRO: 1-BETA-2-BETA-6-ALPHA-TRIS-(ACETYL-OXY)-9-ALPHA-(BENZOYL-OXY)-4-ALPHA-HYDROXY-13-[(2-METHYL-BUTANOYL)-OXY]:	WEAK ACTIVITY
23	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	AGAROFURAN,BETA-DIHYDRO: 1-BETA-2-BETA-6-ALPHA-TRIS-(ACETYL-OXY)-9-ALPHA-(BENZOYL-OXY)-4-ALPHA-HYDROXY-13-[(2-METHYL-BUTANOYL)-OXY]:	WEAK ACTIVITY
24	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	AGAROFURAN,BETA-DIHYDRO: 2-BETA-6-ALPHA-BIS-(ACETYL-OXY)-1-BETA-{(FURAN-3-YL-CARBONYL)-OXY]-4-ALPHA-HYDROXY-9-BETA-13-BIS-{(2-METHYL-BUTANOYL)-OXY]:	None
25	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	AGAROFURAN,BETA-DIHYDRO: 2-BETA-6-ALPHA-BIS-(ACETYL-OXY)-1-BETA-{(FURAN-3-YL-CARBONYL)-OXY]-4-ALPHA-HYDROXY-9-BETA-13-BIS-{(2-METHYL-BUTANOYL)-OXY]:	WEAK ACTIVITY
26	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	AGAROFURAN,BETA-DIHYDRO: 2-BETA-6-ALPHA-BIS-(ACETYL-OXY)-1-BETA-{(FURAN-3-YL-CARBONYL)-OXY]-4-ALPHA-HYDROXY-9-BETA-13-BIS-{(2-METHYL-BUTANOYL)-OXY]:	WEAK ACTIVITY
27	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	AGAROFURAN,BETA-DIHYDRO: 2-BETA-6-ALPHA-BIS-(ACETYL-OXY)-1-BETA-{(FURAN-3-YL-CARBONYL)-OXY]-4-ALPHA-HYDROXY-9-BETA-13-BIS-{(2-METHYL-BUTANOYL)-OXY]:	INACTIVE
28	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	AGAROFURAN,BETA-DIHYDRO: 2-BETA-6-ALPHA-BIS-(ACETYL-OXY)-1-BETA-{(FURAN-3-YL-CARBONYL)-OXY]-4-ALPHA-HYDROXY-9-BETA-13-BIS-{(2-METHYL-BUTANOYL)-OXY]:	WEAK ACTIVITY
29	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	AGAROFURAN,BETA-DIHYDRO: 6-ALPHA-9-ALPHA-13-TRIS-(ACETYL-OXY)-1-BETA-2-BETA-BIS-(BENZOYL-OXY)-4-ALPHA-HYDROXY:	None
30	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	AGAROFURAN,BETA-DIHYDRO: 6-ALPHA-9-ALPHA-13-TRIS-(ACETYL-OXY)-1-BETA-2-BETA-BIS-(BENZOYL-OXY)-4-ALPHA-HYDROXY:	WEAK ACTIVITY
31	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	AGAROFURAN,BETA-DIHYDRO: 6-ALPHA-9-ALPHA-13-TRIS-(ACETYL-OXY)-1-BETA-2-BETA-BIS-(BENZOYL-OXY)-4-ALPHA-HYDROXY:	WEAK ACTIVITY
32	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	AGAROFURAN,BETA-DIHYDRO: 6-ALPHA-9-ALPHA-13-TRIS-(ACETYL-OXY)-1-BETA-2-BETA-BIS-(BENZOYL-OXY)-4-ALPHA-HYDROXY:	INACTIVE
33	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	AGAROFURAN,BETA-DIHYDRO: 6-ALPHA-9-ALPHA-13-TRIS-(ACETYL-OXY)-1-BETA-2-BETA-BIS-(BENZOYL-OXY)-4-ALPHA-HYDROXY:	WEAK ACTIVITY
34	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	AGAROFURAN,BETA-DIHYDRO: 6-ALPHA-13-BIS-(ACETYL-OXY)-1-BETA-2-BETA-9-BETA-TRIS-(BENZOYL-OXY)-4-ALPHA-HYDROXY:	None
35	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	AGAROFURAN,BETA-DIHYDRO: 6-ALPHA-13-BIS-(ACETYL-OXY)-1-BETA-2-BETA-9-BETA-TRIS-(BENZOYL-OXY)-4-ALPHA-HYDROXY:	WEAK ACTIVITY
36	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	AGAROFURAN,BETA-DIHYDRO: 6-ALPHA-13-BIS-(ACETYL-OXY)-1-BETA-2-BETA-9-BETA-TRIS-(BENZOYL-OXY)-4-ALPHA-HYDROXY:	WEAK ACTIVITY
37	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	AGAROFURAN,BETA-DIHYDRO: 6-ALPHA-13-BIS-(ACETYL-OXY)-1-BETA-2-BETA-9-BETA-TRIS-(BENZOYL-OXY)-4-ALPHA-HYDROXY:	WEAK ACTIVITY
38	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	AGAROFURAN,BETA-DIHYDRO: 2-BETA-6-ALPHA-BIS-(ACETYL-OXY)-1-BETA-(BENZOYL-OXY)-4-ALPHA-HYDROXY-9-ALPHA-13-BIS-[(2-METHYL-BUTANOYL)-OXY]:	None
39	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	AGAROFURAN,BETA-DIHYDRO: 2-BETA-6-ALPHA-BIS-(ACETYL-OXY)-1-BETA-(BENZOYL-OXY)-4-ALPHA-HYDROXY-9-ALPHA-13-BIS-[(2-METHYL-BUTANOYL)-OXY]:	ACTIVE
40	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	AGAROFURAN,BETA-DIHYDRO: 2-BETA-6-ALPHA-BIS-(ACETYL-OXY)-1-BETA-(BENZOYL-OXY)-4-ALPHA-HYDROXY-9-ALPHA-13-BIS-[(2-METHYL-BUTANOYL)-OXY]:	ACTIVE
41	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	AGAROFURAN,BETA-DIHYDRO: 2-BETA-6-ALPHA-BIS-(ACETYL-OXY)-1-BETA-(BENZOYL-OXY)-4-ALPHA-HYDROXY-9-ALPHA-13-BIS-[(2-METHYL-BUTANOYL)-OXY]:	INACTIVE
42	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	AGAROFURAN,BETA-DIHYDRO: 2-BETA-6-ALPHA-BIS-(ACETYL-OXY)-1-BETA-(BENZOYL-OXY)-4-ALPHA-HYDROXY-9-ALPHA-13-BIS-[(2-METHYL-BUTANOYL)-OXY]:	ACTIVE

Citation 90425

Citation Details

Summary

Organisms and Their Experiments (1)

Euonymus nanoides (CELASTRACEAE)

Show SPARQL Queries (1)

Query 1